Rodilla Lab

María Mittelbrunn presenting the work of her lab at @senescel.org in Barcelona #SENESCEL25

Registration is open!
Join the II International SENESCEL Conference on Cellular Senescence in Health & Disease 🧬
📍 Nov 6–7, 2025 | PRBB, Barcelona
🌍 senescel2025.senescel.org
Short talks & poster teasers for #ECRs!
@senescel.org @vrodillab.bsky.social

TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak Rozalén et al. report that TIM3 in breast cancer drives a specific mechanism of immune escape during micrometastasis. TIM3+ tumor cells exhibit stemness/EMT features and promote immune-evasion by indu...

We’re thrilled to share our latest publication in
@cp-cancercell.bsky.social and very proud of C. Rozalén for this tour de force uncovering how TIM3⁺ breast cancer cells drive immune evasion during micrometastasis. #CancerImmunology #BreastCancer #Metastasis www.cell.com/cancer-cell/...

Què passarà quan tots aconseguim viure més de cent anys? El metge, investigador, escriptor i divulgador Salvador Macip reflexiona sobre l'envelliment de la població i els límits de la ciència en aquest article publicat a l'últim número de 'La Maleta de Port...

Què passarà quan (no si!) tots aconseguim viure 100 anys? Una mica de filosofia i ciència al @diariARA d'avui.
diumenge.ara.cat/diumenge/pas...

Cx43 enhances response to BRAF/MEK inhibitors by reducing DNA repair capacity Nature Communications - Drug resistance remains a major challenge in cancer treatment. Here, the authors identify Connexin43 as target that enhances BRAF/MEKi efficacy by interfering with DNA...

Our latest paper in @natcomms.nature.com is here!

➡️Cx43 sensitizes BRAF-mutant tumors to BRAF/MEK inhibitors by impairing DNA repair

🔗Open access PDF: rdcu.be/euQkW

Quantification of transcript isoforms at the single-cell level using SCALPEL - Nature Communications Single-cell RNA-seq facilitates the study of transcriptome diversity in individual cells. Here, authors introduce a tool for isoform quantification at the single-cell level using 3’ scRNA-seq data, co...

I’m really happy to present #SCALPEL, a new #Nextflow tool to quantify transcript isoforms at the single-cell level using conventional 3’ scRNA-seq data #scRNA-seq #single-cell #tools #isoforms
www.nature.com/articles/s41...

Another fantastic edition of this great workshop in Coruña on Cellular Aging and Metabolism, CAMS2025, organized by @fafianlabora.bsky.social and María Arufe from @cicaudc.bsky.social @udc.gal and #INIBIC.
Join us in Coruña, July 21-23 (for free!): www.cams2025.com

This is going to be a really cool meeting with great invited speakers, but also offering the possibility to showcase your work independently of your career stage.
It will also be loads of fun in Barcelona, with the most friendly and welcoming community ☺️
Rush to register at senescel2025.senescel.org

📢 Registration open!

Explore the latest advances in cellular #senescence at the upcoming International Conference of @senescel.org 🧬

📅 06-07 November 2025
📍 Barcelona
More information ⬇️
senescel2025.senescel.org

Co-organised by IJC Group Leader Dr. Verónica Rodilla ‪@vrodillab.bsky.social‬

6⃣DAYS left for Early bird registration!

⏰Deadline: 16 July

👉And don't forget, there are reduced prices for ASEICA, ASPIC, @helloeacr.bsky.social, SEOM , SEOR, @sebbm.bsky.social, SEAP, Contra Cancer, Cerfa, Ceru, CIBERONC&FESEO members!

✍️https://www.aseica.es/20th-aseica-international-congress

Dear senescence-addicted community!
Registration for the II International SENESCEL Conference is now open!
Check out our amazing lineup of invited speakers and join us on November 6th in Barcelona!
🔗 senescel2025.senescel.org
JOIN US to learn how to "senesce" more elegantly!

Rodilla Team & Joan Jané Mateu (fundador de Jané Mateu Foundation)

Proyecto financiado!

Ayer tuvimos el inmenso placer de asistir a la entrega de premios de la Fundación Jané Mateu (3.ª convocatoria) y agradecerles su apoyo al proyecto que llevamos a cabo en @carrerasijc.bsky.social.

¡Juntos, #Imparables e #Incansables contra el #linfoma!

🚨We are looking for post-doctoral candidates to apply for a MSCA fellowship.

Projects on gene regulation in neural development or neurdegenerative diseases using single-cell omics.

Computational & wet-lab candidates are welcomed! #postdoc #MSCA #Barcelona #singlecell.

📢 Don’t miss the next seminar of the Cancer Research Program!

🗓 Wednesday, June 4 🕑 2:00 PM 📍 Josep Marull Hall

🗣️ Sergi Cuartero, PhD – @carrerasijc.bsky.social

🧬 Understanding CEBPA mutations in AML

👉
researchmar.net/agenda/957/u...

@hospitaldelmar.bsky.social

CarrerasLeaders - An innovative and international Postdoctoral Programme An innovative and international Postdoctoral Programme

The deadline is approaching. Apply for the @carrerasleaders.bsky.social‬ three year fellowship in blood cancers by June 1, 2025. Visit carrerasleaders.eu for more information.

Curious about the role of #senescence in pituitary tumors? 🔍🧠
Our latest review in @jne-editor.bsky.social explores its relevance in #pituitary tumor biology and the key molecular players driving this process. Check it out!
onlinelibrary.wiley.com/doi/full/10....

🎙️ "El Síndrome de Rett es especialmente cruel, las niñas nacen aparentemente de manera normal, sin ninguna dificultad, y adquiriendo las habilidades que se esperan durante el primer año de vida."

📺 Entrevista de la Dra. Guil para @rtvenoticias.bsky.social

#RareDiseaseDay 💙 💪

Please RT: In my lab we are looking for computational #postdoc researchers to apply to a #juandelacierva or #embo postdoctoral fellowships to work on projects on post-transcriptional regulation on single-cell data (method development and/or data analysis). Contact me if you are interested!

VHIO's VIDA program receives a Marie Skłodowska-Curie Actions COFUND grant to recruit 12 postdoctoral researchers - VHIO The Vall d’Hebron Institute of Oncology (VHIO) has received one of the COFUND grants under the Marie Skłodowska-Curie Actions (MSCA)...

@vhio.bsky.social has an upcoming call for postdoc positions, jointly funded by the MSCA. Come join us to help improve our understanding of cancer, develop new therapies, and improve patient's lives!

Keep an eye out to apply early 2025! vhio.net/2024/12/03/v...